CelldeepCelldeep Facebook ad: “Check Now”
Ran for 40 days, from February 18 to March 30, 2026, the last day Crush saw it.
Run by Celldeep on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)
Want an ad like this for your product?
Crush makes new ad images for your product from this ad: your logo, your product photo, your offer.
Trials from $19.95 USD, then $79.95 USD a month. Cancel anytime.
About this ad
- Meta Ad Library ID
- 1448506106724789
- Platforms
- Facebook, Instagram and Audience Network
- Relaunches
- 0
Ad text
Reta GLP-1 is changing how clinicians think about medical weight loss. Unlike single-path therapies, Reta is a triple agonist (GLP-1, GIP, and Glucagon) designed to address appetite control, insulin resistance, and energy expenditure at the same time. This isn’t about crash dieting or shortcuts. It’s a physician-guided approach focused on real metabolic change, not just the number on the scale. 💰 Starting at $599 🩺 Medically supervised. Science-driven. 👉 Tap “Learn More” to see if Reta is right for you.
Where the ad sends people
fb.me
Check Now 👉
Learn more: fb.me(opens in a new tab)
